Related Experiment Videos
Drugs in pregnancy. Cardiovascular disease
1Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, UK.
Best Practice & Research. Clinical Obstetrics & Gynaecology
|January 22, 2002
Summary
Treating cardiovascular disease in pregnancy involves careful consideration of medication risks versus benefits. Pre-pregnancy counseling and non-drug therapies are crucial for managing heart conditions during gestation.
Area of Science:
- Cardiology
- Maternal-Fetal Medicine
- Pharmacology
Background:
- Cardiovascular disease (CVD) is a significant concern during pregnancy.
- Management of CVD in pregnant individuals often parallels non-pregnant populations.
- Limited safety data necessitates caution with many medications.
Purpose of the Study:
- To review the available therapeutic options for pregnant individuals with cardiovascular disease.
- To highlight considerations for drug safety and alternative treatments.
- To emphasize the importance of pre-pregnancy counseling.
Main Methods:
- Literature review of therapeutic strategies for cardiovascular disease in pregnancy.
- Analysis of drug contraindications and safety profiles.
- Discussion of non-pharmacological treatment options.
Main Results:
- Few medications are absolutely contraindicated in pregnancy.
- Risk-benefit assessment is paramount for maternal and fetal well-being.
- Non-pharmacological interventions are viable alternatives.
Conclusions:
- Cardiovascular disease management during pregnancy requires careful drug selection and risk assessment.
- Pre-pregnancy counseling is essential for women of childbearing age on long-term medication.
- Exploring non-pharmacological treatments like radio-frequency ablation is recommended.